TIPE2 Associated With Kidney Transplant
TIPE2
Department of Renal Transplantation, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
1 other identifier
observational
93
0 countries
N/A
Brief Summary
TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. The investigators want to know whether TIPE2 is a risk factor for graft loss and gives rise to the immune dysfunction in renal transplant patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 28, 2010
CompletedFirst Posted
Study publicly available on registry
January 29, 2010
CompletedJanuary 29, 2010
October 1, 2009
January 28, 2010
January 28, 2010
Conditions
Keywords
Eligibility Criteria
kidney transplant patients and healty Volunteers
You may qualify if:
- long-term surival(\>5year),AR and CR kidney transplant patients and healty Volunteers as control
You may not qualify if:
- without hepatitis , tumor and infections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 28, 2010
First Posted
January 29, 2010
Study Start
October 1, 2009
Last Updated
January 29, 2010
Record last verified: 2009-10